| http://www.w3.org/ns/prov#value | - This was a proof-of-principle demonstration of a technology that could be very useful against HIV, influenza and other highly variable viruses that have been difficult to stop using traditional vaccine-design strategies, said William R. Schief, associate professor of immunology at TSRI.
|
